Approximately 90% of extensive breast and/or ovarian cancer families have loss of function germline mutations in the tumour suppressor genes BRCA1 or BRCA2 (17q21 and 13q12–q13, respectively). Here, BRCA1 is linked to ovarian carcinoma.